© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
September 19, 2022
Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.
April 13, 2018
Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
September's Top 5 Infectious Disease Stories
COVID-19 Vaccine Boosters: Roadblocks, the Future, and Communicating the Benefits to Patients
CDC Updates Pneumococcal Conjugate Vaccine Recommendations
Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill